We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Evaluating the efficacy of Enhancer of Zeste Homolog 2 (EZH2) inhibitors in combination with anti-GD2/isotretinoin for the treatment of high-risk neuroblastoma: a pre-clinical study
Dissecting the role of MYCN in neuroblastoma initiation
Establishment of an in vitro model of neuroblastoma initiation using pluripotent stem cell differentiation
Clinical and biological factors associated with relapse and length of survival following relapse in UK neuroblastomas
Understanding and improving the mechanism of action of anti-GD2 monoclonal antibody therapy in neuroblastoma
Targeting the Fanconi Anaemia pathyway in neuroblastoma
Overcoming drug resistance for efficacious neuroblastoma therapeutics
A pilot study of expression profiling using RNAseq from formalin fixed neuroblastoma and paired diagnostic and relapsed frozen neuroblastomas.
A genome wide study of unresectable, MYCN non-amplied, unfavourable histology neuroblastomas in patients older than 18 months of age
